RegCell, Inc.
PrivateLast Round
Seed
Mar 18, 2025
Total Funding Raised
$45.8M
Company Overview
RegCell, Inc. is a biotechnology company that develops first-in-class regulatory T-cell (Treg) therapies for autoimmune diseases and transplantation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RegCell, Inc. Comps
Public and private peers based on sector, stage, and business model.
RegCell, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 18, 2025 | ||||
| Grant | Mar 18, 2025 |
Key People
Founding team and executive leadership
RegCell, Inc. Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2025
$37.3M raised in a grant round.
- Mar 18, 2025
Steven B. Kanner joins the Board of Directors.
RegCell, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RegCell, Inc.'s valuation, stock price, and market status.
